Anthony F Shields

Anthony F Shields

UNVERIFIED PROFILE

Are you Anthony F Shields?   Register this Author

Register author
Anthony F Shields

Anthony F Shields

Publications by authors named "Anthony F Shields"

Are you Anthony F Shields?   Register this Author

100Publications

2074Reads

25Profile Views

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

CA Cancer J Clin 2019 Jul 22;69(4):305-343. Epub 2019 May 22.

Professor of Medicine and Oncology, Director, Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Institute, MedStar Georgetown Cancer Institute, Washington, DC.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.3322/caac.21560
Publisher Site
http://dx.doi.org/10.3322/caac.21560DOI Listing
July 2019

Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer.

Methods Mol Biol 2019 ;1974:355-369

Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9220-1_24DOI Listing
January 2019

Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.

Oncologist 2018 Oct 27;23(10):1171-1177. Epub 2018 Apr 27.

Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263127PMC
October 2018

Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model.

Biomaterials 2018 09 13;178:183-192. Epub 2018 Jun 13.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA; Department of Pharmaceutical Sciences, Wayne State University School of Pharmacy and Health Sciences, Detroit, MI, USA; Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-Universität München, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2018.06.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056733PMC
September 2018

Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery.

Mol Imaging Biol 2018 06;20(3):340-351

Department of Oncology, Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-017-1142-2DOI Listing
June 2018

Intended Versus Inferred Treatment After F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.

J Nucl Med 2018 03 30;59(3):421-426. Epub 2017 Nov 30.

Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.205047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424220PMC
March 2018

Hospice Admission and Survival After F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.

J Nucl Med 2018 03 28;59(3):427-433. Epub 2017 Dec 28.

Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.205120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424219PMC
March 2018

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

N Engl J Med 2018 Mar;378(13):1177-1188

From the Divisions of Medical Oncology (A.G.) and Biomedical Statistics and Informatics (Q.S., J.P.M., L.A.R., D.J.S.), Mayo Clinic, Rochester, MN; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST, Genoa (A.F. Sobrero), Ospedale Papa Giovanni XXIII, Bergamo (R.L.), and IRCCS Mario Negri Institute for Pharmacological Research, Milan (V.T.) - all in Italy; Karmanos Cancer Institute, Wayne State University, Detroit (A.F. Shields); National Cancer Center Hospital East, Chiba (T. Yoshino), Yokohama City University School of Medicine, Yokohama (T. Yamanaka), and the University of Tokyo, Tokyo (T.W.) - all in Japan; the Institute of Cancer Sciences, University of Glasgow, Glasgow (J.P.), the University of Oxford, Oxford (R.K.), Christie Hospital, Manchester (M.S.), and University Hospital Southampton, Southampton (T.I.) - all in the United Kingdom; Hôpital Européen Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University (J.T.), and Saint-Antoine Hospital and Sorbonne Universités, Pierre and Marie Curie University-Paris 6 (T.A.), Paris, and Methodology and Quality of Life Unit, INSERM Unité 1098, Besançon (D.V.) - all in France; the Department of Medical Oncology, University Hospital of Heraklion, Faculty of Medicine, University of Crete, Heraklion (J.S.), and Bioclinic Thessaloniki, Thessaloniki (I.B.) - both in Greece; Dana-Farber Cancer Institute, Boston (J.A.M.); and Duke Cancer Institute, Durham, NC (D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1713709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426127PMC
March 2018

Imaging bone-marrow activity with F-fluorothymidine PET.

Lancet Haematol 2018 01 14;5(1):e8-e9. Epub 2017 Dec 14.

Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30226-0DOI Listing
January 2018

A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer.

Mol Imaging Biol 2017 12;19(6):810-816

Karmanos Cancer Institute, Wayne State University, 4233 Hudson Weber Cancer Center, 4100 John R, Detroit, MI, 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-017-1057-yDOI Listing
December 2017

Preclinical Applications of 3'-Deoxy-3'-[F]Fluorothymidine in Oncology - A Systematic Review.

Theranostics 2017 1;7(1):40-50. Epub 2017 Jan 1.

European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany.; Department of Geriatric Medicine, Johanniter Hospital, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.16676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196884PMC
October 2017

What is the optimal duration of adjuvant therapy in colon cancer?

Clin Adv Hematol Oncol 2017 Oct;15(10):734-738

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

View Article

Download full-text PDF

Source
October 2017

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.

Oncotarget 2017 Oct 21;8(49):86356-86368. Epub 2017 Sep 21.

Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689690PMC
October 2017

Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.

Anticancer Res 2017 03;37(3):1213-1218

Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11436DOI Listing
March 2017

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.

J Clin Oncol 2016 12 31;34(34):4142-4150. Epub 2016 Oct 31.

Albiruni R. Abdul Razak and Lee-Anne Stayner, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Morten Mau-Soerensen and Ulrik Lassen, Rigshospitalet, Copenhagen, Denmark; Nashat Y. Gabrail, Gabrail Cancer Institute, Canton, OH; John F. Gerecitano, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY; Anthony F. Shields, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Thaddeus J. Unger, Jean R. Saint-Martin, Robert Carlson, Yosef Landesman, Dilara McCauley, Tami Rashal, Mansoor R. Mirza, Michael Kauffman, and Sharon Shacham, Karyopharm Therapeutics, Newton, MA; and Richard Kim and Amit Mahipal, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562433PMC
December 2016

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.

J Clin Oncol 2016 08 20;34(24):2874-80. Epub 2016 Jun 20.

Louis A. Penner, Terrance L. Albrecht, Tanina Foster, Felicity W.K. Harper, Lauren M. Hamel, Anthony F. Shields, Shirish Gadgeel, Michael S. Simon, and Susan Eggly, Wayne State University; Robert Chapman, Henry Ford Health Care System, Detroit; Richard Gonzalez and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI; John F. Dovidio, Yale University, New Haven, CT; and Nao Hagiwara, Virginia Commonwealth University, Richmond, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012663PMC
August 2016

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).

Pharmacogenet Genomics 2016 Mar;26(3):133-7

aDepartment of Molecular Pharmacology and Experimental Therapeutics (MPET), Mayo Clinic Cancer Center bAlliance Statistics and Data Center cDivision of Medical Oncology dDivision of Gastroenterology, Mayo Clinic, Rochester, Minnesota eDepartment of Surgery, Cancer Prevention and Control Program, University of Hawaii Cancer Center, Honolulu, Hawaii fDepartment of Medicine, Center for GI Oncology, The University of Chicago Medicine, Chicago, Illinois gDivision of Hematology Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee hSurgical Oncology Associates of South Texas, San Antonio, Texas iDepartment of Hematology Oncology, Lehigh Valley Health Network, John and Dorthy Morgan Cancer Center, Allentown, Pennsylvania jDepartment of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan kDepartment of Hematology/Oncology, Division of Medical Oncology, The Ohio State University Medical Center, Columbus, Ohio, USA lDepartment of Medicine, Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738010PMC
March 2016

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

J Natl Cancer Inst 2015 Nov 14;107(11). Epub 2015 Sep 14.

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA (CJA, GY, MJO, RWB, TFW, HCP, AFS, JCL, DPR, AA, LSE, NB, GS, JFE, JMR, DFMJr, MRM, BTM, PJW, SS, MSR, NW); Department of Medicine, University of Florida Health, Gainesville, FL (CJA); NRG Oncology and the University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA (GY); Glendale Memorial Hospital, Glendale, CA (RWB); CCOP Christiana Care Health Systems, Newark, DE (TFW); Mayo Clinic, Rochester, MN and the ALLIANCE, Boston, MA (HCP); Wayne State University, Karmanos Cancer Institute, Detroit, MI and SWOG, San Antonio, TX (AFS); Emory University, Department of Radiation Oncology, Atlanta, GA and ECOG/ACRIN, Rochester, MN (JCL); Massachusetts General Hospital Cancer Center and the ALLIANCE, Boston, MA (DPR); Kaiser Permanente, Fremont, CA (AA); Novant Health Forsyth Medical Center, Winston-Salem, NC (LSE); University of Pittsburgh, Pittsburgh, PA (NB); Missouri Valley Cancer Consortium CCOP, Omaha, NE (GS); Florida Cancer Specialists, Fort Myers, FL (JFE); Beaumont Hospital System, Royal Oak, MI (JMR); Cancer Center of Kansas, Wichita, KS (DFMJr); Stroger Hospital Chicago MU-NCORP, Chicago, IL (MRM); Montana Cancer Consortium, Billings, MT (BTM); Oncology and Hematology Care, Cincinnati, OH (PJW); UF Health Cancer Center, Orlando FL (MSR); Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (NW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849360PMC
November 2015

18F-FLT PET Evaluation of Radiation Response.

J Nucl Med 2015 Jun 9;56(6):813-4. Epub 2015 Apr 9.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.155507DOI Listing
June 2015

PET scans as a predictive marker of survival in advanced colorectal cancer.

Clin Colorectal Cancer 2015 Mar 23;14(1):35-40. Epub 2014 Oct 23.

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2014.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342990PMC
March 2015

Positron emission tomography for subsequent treatment strategy in oncology.

J Clin Oncol 2014 Sep 14;32(25):2811-2. Epub 2014 Jul 14.

Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.8677DOI Listing
September 2014

Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry.

J Nucl Med 2014 Jul 12;55(7):1054-61. Epub 2014 May 12.

Department of Radiology, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.113.135475DOI Listing
July 2014

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

J Clin Oncol 2014 Jun 5;32(18):1927-34. Epub 2014 May 5.

Michael J. O'Connell, Linda H. Colangelo, Robert W. Beart, Nicholas J. Petrelli, Carmen J. Allegra, Saima Sharif, Henry C. Pitot, Anthony F. Shields, David S. Parda, Mohammed Mohiuddin, Amit Arora, Lisa S. Evans, Nathan Bahary, Gamini S. Soori, Janice Eakle, John M. Robertson, Dennis F. Moore Jr, Michael R. Mullane, Benjamin T. Marchello, Patrick J. Ward, Timothy F. Wozniak, Mark S. Roh, Greg Yothers, Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers; David S. Parda, Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital; Nathan Bahary, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robert W. Beart, Colorectal Surgery Institute, Glendale Memorial Hospital, Glendale; Amit Arora, Kaiser Permanente Hayward, Hayward, CA; Nicholas J. Petrelli, Timothy F. Wozniak, Helen F. Graham Cancer Center at Christiana Care Health Service, Newark, DE; Carmen J. Allegra, University of Florida, Gainesville; Janice Eakle, Florida Cancer Specialists, Sarasota; Mark S. Roh, MD Anderson Cancer Center Orlando Health, Orlando, FL; Henry C. Pitot, Mayo Clinic, Rochester, MN; Anthony F. Shields, Karmanos Cancer Institute/Southwest Oncology Group, Detroit; John M. Robertson, Beaumont Hospital System, Royal Oak, MI; Jerome C. Landry, Eastern Cooperative Oncology Group/Emory University, Winship Cancer Institute, Atlanta, GA; David P. Ryan, Massachusetts General Hospital Cancer Center, Boston, MA; Lisa S. Evans, Community Clinical Oncology Program, Southeast CCC Novant Health Derrick L. Davis Forsyth Medical Center, Winston-Salem, NC; Gamini S. Soori, Missouri Valley Cancer Consortium Community Clinical Oncology Program, Omaha, NE; Dennis Moore Jr, Community Clinical Oncology Program, Wichita/St Francis Regional Medical Center/Via Christi Regional Medical Center, Wichita, KS; Michael R. Mullane, Minority-Based Community Clinical Oncology Program John H. Stroger Jr Hospital

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.53.7753
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.7753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050205PMC
June 2014

Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.

J Nucl Med 2014 Apr 27;55(4):574-81. Epub 2014 Feb 27.

Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.

View Article

Download full-text PDF

Source
https://www.cancerpetregistry.org/pdf/Hillner-JNM-55-574-201
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.113.130005
Publisher Site
http://dx.doi.org/10.2967/jnumed.113.130005DOI Listing
April 2014

PET imaging of proliferation with pyrimidines.

J Nucl Med 2013 Jun 14;54(6):903-12. Epub 2013 May 14.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://snmmi.files.cms-plus.com/docs/JNM_CE_Article_June_201
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.112.112201
Publisher Site
http://dx.doi.org/10.2967/jnumed.112.112201DOI Listing
June 2013

Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.

J Nucl Med 2012 May 23;53(5):831-7. Epub 2012 Mar 23.

Department of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298-0170, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/content/53/5/831.full.pdf
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.112.103911
Publisher Site
http://dx.doi.org/10.2967/jnumed.112.103911DOI Listing
May 2012

PET imaging of tumor growth: not as easy as it looks.

Clin Cancer Res 2012 Mar 24;18(5):1189-91. Epub 2012 Jan 24.

Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, Michigan 48201-2013, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-3198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294137PMC
March 2012

Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry.

Mol Imaging Biol 2011 Feb;13(1):161-5

Department of Internal Medicine, Virginia Commonwealth University, 1101 E Marshall St Room 7013, Richmond, VA 23298-0170, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11307-010-0427-5
Publisher Site
http://dx.doi.org/10.1007/s11307-010-0427-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023024PMC
February 2011

Clinicopathological analysis of primary epithelial appendiceal neoplasms.

Med Oncol 2010 Dec 23;27(4):1073-8. Epub 2009 Oct 23.

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-009-9337-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883058PMC
December 2010

PET and PET/CT reports: observations from the National Oncologic PET Registry.

J Nucl Med 2010 Jan 15;51(1):158-63. Epub 2009 Dec 15.

Department of Radiology, Duke University School of Medicine, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.109.066399
Publisher Site
http://dx.doi.org/10.2967/jnumed.109.066399DOI Listing
January 2010

Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.

Mol Imaging Biol 2006 May-Jun;8(3):141-50

Karmanos Cancer Institute, Department of Medicine, Wayne State University, 4100 John R Street 4HWCRC, Detroit, MI 48201-2013, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11307-006-0039-2
Publisher Site
http://dx.doi.org/10.1007/s11307-006-0039-2DOI Listing
June 2009

Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine.

Ann Pharmacother 2009 Apr 31;43(4):761-6. Epub 2009 Mar 31.

Department of Hematology/Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1L528DOI Listing
April 2009

The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.

Cancer 2009 Jan;115(2):410-8

Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298-0170, USA. hillner@vcuedu

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24000DOI Listing
January 2009

Preface-imaging in cancer.

Cancer Metastasis Rev 2008 Dec;27(4):543-4

Karmanos Cancer Institute, Detroit, MI 48201-2013, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10555-008-9150-y
Publisher Site
http://dx.doi.org/10.1007/s10555-008-9150-yDOI Listing
December 2008

The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.

Cancer Metastasis Rev 2008 Dec;27(4):575-87

Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-008-9148-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086165PMC
December 2008

Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.

J Nucl Med 2008 Dec 7;49(12):1928-35. Epub 2008 Nov 7.

Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.108.056713
Publisher Site
http://dx.doi.org/10.2967/jnumed.108.056713DOI Listing
December 2008

Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.

Eur J Nucl Med Mol Imaging 2008 Aug 12;35(8):1480-8. Epub 2008 Feb 12.

Karmanos Cancer Institute, Wayne State University, 4100 John R, 4 HWCRC, Detroit, MI 48201-2013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-008-0738-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826914PMC
August 2008

Imaging of cell proliferation: status and prospects.

J Nucl Med 2008 Jun;49 Suppl 2:64S-80S

Department of Radioimmunotherapy, City of Hope, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.107.046391
Publisher Site
http://dx.doi.org/10.2967/jnumed.107.046391DOI Listing
June 2008

Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

J Clin Oncol 2008 May 24;26(13):2155-61. Epub 2008 Mar 24.

Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, 1101 E Marshall St, Room 7013, Richmond, VA 23298-0170, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.5631DOI Listing
May 2008

Computerized detection of lung tumors in PET/CT images.

Conf Proc IEEE Eng Med Biol Soc 2006 ;1:2320-3

Department of Electrical and Computer Engineering, Wayne State University, Detroit, MI 48202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1109/IEMBS.2006.259238DOI Listing
March 2008

The National Oncologic PET Registry (NOPR): design and analysis plan.

J Nucl Med 2007 Nov 17;48(11):1901-8. Epub 2007 Oct 17.

Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0170, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.107.043687DOI Listing
November 2007

Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.

J Nucl Med 2007 Sep;48(9):1436-41

Karmanos Cancer Institute, Wayne State University, 4100 John R. Street, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.107.042762DOI Listing
September 2007

The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development.

AJR Am J Roentgenol 2007 Apr;188(4):1109-13

Foley Hoag, LLP, 155 Seaport Blvd., Boston, MA 02210-2600, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.06.1175DOI Listing
April 2007

Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs.

J Nucl Med 2007 Apr;48(4):655-60

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201-2013, USA.

View Article

Download full-text PDF

Source
April 2007

A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.

Am J Clin Oncol 2007 Apr;30(2):101-5

Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000251223.98193.f4DOI Listing
April 2007

Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.

Invest New Drugs 2007 Feb 26;25(1):69-75. Epub 2006 Aug 26.

Division of Oncology, Department of Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9005-8DOI Listing
February 2007

Phase I study of bryostatin 1 and gemcitabine.

Clin Cancer Res 2006 Dec;12(23):7059-62

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1419DOI Listing
December 2006

PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.

J Nucl Med 2006 Oct;47(10):1649-52

Department of Pediatrics, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
October 2006

Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.

Cancer Chemother Pharmacol 2006 Feb 7;57(3):343-8. Epub 2005 Jul 7.

Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201-2013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0037-0DOI Listing
February 2006

A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

Invest New Drugs 2005 Dec;23(6):583-90

Karmanos Cancer Institute, Wayne State University, 4100 John R Street, Detroit, MI, 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-005-1028-zDOI Listing
December 2005

A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention.

Eur J Nucl Med Mol Imaging 2005 Nov 1;32(11):1269-75. Epub 2005 Jul 1.

Karmanos Cancer Institute, 4100 John R Street, 4 HWCRC, Detroit, MI 48201-2013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-005-1813-0DOI Listing
November 2005

A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary.

Am J Clin Oncol 2005 Apr;28(2):152-6

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000142590.70472.e2DOI Listing
April 2005

Imaging DNA synthesis in vivo with 18F-FMAU and PET.

J Nucl Med 2005 Feb;46(2):292-6

Department of Medicine, Wayne State University, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
February 2005

Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors.

Invest New Drugs 2005 Jan;23(1):57-62

Division of Hematology/Oncology, Wayne State University, Karmanos Cancer Institute, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:DRUG.0000047106.20104.a7DOI Listing
January 2005

Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.

Eur J Nucl Med Mol Imaging 2005 Jan;32(1):15-22

Karmanos Cancer Institute, Departments of Medicine, Radiology and Pediatrics, Wayne State University, 4100 John R Street, 4 HWCRC, Detroit, MI, 48201-2013, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00259-004-1713-8
Publisher Site
http://dx.doi.org/10.1007/s00259-004-1713-8DOI Listing
January 2005

PET imaging of cellular proliferation.

Radiol Clin North Am 2005 Jan;43(1):153-67

Division of Nuclear Medicine, Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Room NN203, Box 356113, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
January 2005